Allergic Rhinitis
📧 Sign up to get email alerts when something new happens for Allergic Rhinitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-03-27Clinical Trial Update: Effects of Allergic Rhinitis on the Nasal/Sinus Microbiome
The clinical trial evaluated how allergic rhinitis influences the nasal and sinus microbiome. The study status is COMPLETED.
-
CLINICAL_TRIALS research · 2014-03-11Clinical Trial Update: Hair Cortisol in Asthma or Allergic Rhinitis Treated With Topical Corticosteroids
ClinicalTrials.gov provides an update on measuring hair cortisol in people with asthma or allergic rhinitis treated with topical corticoster…
-
FDA approval · 2014-03-07FDA Approved: CLARINEX-D 12 HOUR — Supplemental Application (Organon LLC)
FDA approved a supplemental NDA for CLARINEX-D 12 HOUR, a desloratadine and pseudoephedrine sulfate combination, to expand its regulatory ap…
-
CLINICAL_TRIALS trial_result · 2014-03-06Clinical Trial Update: Retrospective Record Review of Adults and Children Advised for Allergen Immunotherapy (MK-7243-022)
A retrospective record review evaluated adults and children advised to receive allergen immunotherapy with MK-7243-022. The study is complet…
-
CLINICAL_TRIALS trial_result · 2014-03-05Clinical Trial Update: Effect of a L. Paracasei Strain on Grass Pollen Allergic Rhinitis Subjects [NA]
Nestlé-sponsored trial evaluating a Lactobacillus paracasei probiotic for grass pollen–related allergic rhinitis has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2014-02-24FDA Approved: ZYRTEC ALLERGY — Supplemental Application (Kenvue Brands LLC)
FDA approved a supplemental application for ZYRTEC ALLERGY (cetirizine hydrochloride) from Kenvue Brands LLC, likely for labeling or indicat…
-
FDA approval · 2014-02-21FDA Approved: ZYRTEC ALLERGY — Supplemental Application (Kenvue Brands LLC)
FDA approved a supplemental application for ZYRTEC ALLERGY (cetirizine hydrochloride) submitted by Kenvue Brands LLC.
-
CLINICAL_TRIALS trial_result · 2014-02-20Clinical Trial Update: Is Levocetirizine Less Sedating Than Cetirizine? [Phase 4]
This Phase 4 trial compares the sedative effects of levocetirizine and cetirizine in allergic rhinitis; results were posted in 2014.
-
FDA label_change · 2014-02-14FDA Approved: XYZAL — Supplemental Application (Chattem, Inc.)
FDA has received a supplemental application for XYZAL (levocetirizine dihydrochloride) from Chattem, Inc.
-
FDA approval · 2014-02-12FDA Approved: ZYRTEC-D — Supplemental Application (Kenvue Brands LLC)
The FDA approved a supplemental application for ZYRTEC-D, filed by Kenvue Brands LLC. ZYRTEC-D combines cetirizine hydrochloride and pseudoe…
-
FDA approval · 2014-01-30FDA Approved: ALLEGRA-D ALLERGY AND CONGESTION — Supplemental Application (Chattem, Inc.)
FDA approved a supplemental application for ALLEGRA-D ALLERGY AND CONGESTION (fexofenadine hydrochloride and pseudoephedrine hydrochloride) …
-
CLINICAL_TRIALS trial_result · 2014-01-29Clinical Trial Update: Safety Clinical Trial With Depigopid 50% Grasses/50% Olea Europaea(2000DPP/ml) or Depigoid 50% Grasses/50% Parietaria Judaica(2000DPP/ml). [Phase 2]
A Phase 2 safety trial evaluating two immunotherapy formulations for grass and tree pollen allergies has completed, focusing on allergic rhi…
-
FDA approval · 2014-01-28FDA Approved: SINGULAIR — Supplemental Application (Organon LLC)
FDA approved a supplemental application for Singulair (montelukast sodium) submitted by Organon LLC.
-
CLINICAL_TRIALS trial_result · 2014-01-27Clinical Trial Update: Intranasal CO2 for Allergic Rhinitis [NA]
A completed clinical trial tested intranasal carbon dioxide for allergic rhinitis, with results posted in 2014.
-
FDA approval · 2014-01-26FDA Approved: ALLERGY RELIEF — Supplemental Application (Ohm Laboratories Inc.)
FDA approved a supplemental application for Allergy Relief containing loratadine from Ohm Laboratories Inc., indicating a regulatory update …
-
CLINICAL_TRIALS trial_result · 2014-01-22Clinical Trial Update: A Dose Response Evaluation of SLITone Ultra HDM Mix Immunotherapy [Phase 2]
Phase 2 dose-response evaluation of SLITone Ultra HDM Mix Immunotherapy for allergic rhinitis has completed.
-
CLINICAL_TRIALS trial_result · 2014-01-22Clinical Trial Update: Avanz Phleum Pratense Maintenance Dose [Phase 2, Phase 3]
This clinical trial update reports on the Phase 2/3 maintenance-dose study of Avanz Phleum Pratense for allergic rhinoconjunctivitis conduct…
-
FDA approval · 2014-01-21FDA Approved: DYMISTA — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for DYMISTA, a combination of azelastine hydrochloride and fluticasone propionate, from Viatris …
-
CLINICAL_TRIALS research · 2014-01-20Clinical Trial Update: Allergen Immunotherapy in Allergic Patients
A clinical trial update from Istanbul University investigates allergen immunotherapy for allergic rhinitis; the current status is not specif…
-
CLINICAL_TRIALS trial_result · 2014-01-14Clinical Trial Update: Effect of a Probiotic on Grass Pollen Allergic Rhinitis Subjects [NA]
This clinical trials update reports a completed study evaluating the effect of a probiotic on grass pollen–induced allergic rhinitis.
-
CLINICAL_TRIALS trial_result · 2014-01-09Clinical Trial Update: Influence of Probiotics on Atopy, Immunological Responses and Gut Microflora - Follow-up to 5 Years [Phase 2]
This Phase 2 follow-up trial update reports five-year outcomes on the use of probiotics affecting atopy, immune responses, and gut microbiot…
-
CLINICAL_TRIALS trial_result · 2014-01-09Clinical Trial Update: Effect of House Dust Mite Allergen Challenge in Persons Using 1200 mg Gamma Tocopherol Supplements [Phase 1]
This completed Phase 1 trial investigates how daily 1200 mg gamma-tocopherol supplementation affects responses to house dust mite allergen e…
-
CLINICAL_TRIALS trial_result · 2014-01-09Clinical Trial Update: Influence of Probiotics on Atopy With Focus on Respiratory Allergic Diseases- Follow-up to 7 Years
Seven-year follow-up update from a trial evaluating the influence of probiotics on atopy in respiratory allergic diseases, including asthma …
-
CLINICAL_TRIALS withdrawal · 2014-01-09Clinical Trial Update: Phase 2 Study in Adults Sensitized to Short Ragweed [Phase 2]
A Phase 2 trial evaluating a treatment for allergic rhinitis in adults sensitized to short ragweed has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2014-01-08Clinical Trial Update: Innate Immunity and the Allergic Response [NA]
This update reports on a completed clinical trial studying the role of innate immunity in the allergic response for nasal allergies.